Literature DB >> 9384911

Beta-blockers and the treatment of aggression.

T Haspel1.   

Abstract

This review assesses the usefulness of beta-blockers in the treatment of aggression and describes the parameters for their clinical use. A Medline search using the terms "beta-blockers," "aggression," "propranolol," and "brain injury" identified relevant journal articles published in English between 1977 and 1993. Open, prospective and double-blind, placebo-controlled studies, as well as case reports, were included. Beta-blockers appear to be effective in decreasing the frequency and intensity of aggressive outbursts associated with a wide variety of conditions, such as dementias, attention-deficit disorder, personality disorders, Korsakoff's psychosis, posttraumatic stress disorder, schizophrenia, profound mental retardation, autism, and brain injury. A general discussion attempts to resolve some of the issues surrounding the possible mechanisms of beta-blocker effects, reviews the anatomic and neurochemical bases of aggression, and explores implications of the clinical use of beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9384911     DOI: 10.3109/10673229509017146

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  8 in total

1.  Diagnosing and managing violence.

Authors:  Jeffrey C Fetter
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Excessive aggression as model of violence: a critical evaluation of current preclinical methods.

Authors:  Klaus A Miczek; Sietse F de Boer; Jozsef Haller
Journal:  Psychopharmacology (Berl)       Date:  2013-02-21       Impact factor: 4.530

3.  Successful management of difficult-to-treat aggression with low-dose propranolol in a patient with intellectual disability: a case report.

Authors:  Ravi Philip Rajkumar
Journal:  Prim Care Companion CNS Disord       Date:  2012-10-04

Review 4.  The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.

Authors:  David Q Beversdorf
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

5.  Concomitant medication of psychoses in a lifetime perspective.

Authors:  Maria Vares; Peter Saetre; Pontus Strålin; Sten Levander; Eva Lindström; Erik G Jönsson
Journal:  Hum Psychopharmacol       Date:  2011-06-22       Impact factor: 1.672

Review 6.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 7.  Neuropsychiatric Consequences of Lipophilic Beta-Blockers.

Authors:  Sabina Alexandra Cojocariu; Alexandra Maștaleru; Radu Andy Sascău; Cristian Stătescu; Florin Mitu; Maria Magdalena Leon-Constantin
Journal:  Medicina (Kaunas)       Date:  2021-02-09       Impact factor: 2.430

Review 8.  The physician's unique role in preventing violence: a neglected opportunity?

Authors:  John C Umhau; Karysse Trandem; Mohsin Shah; David T George
Journal:  BMC Med       Date:  2012-11-23       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.